Doxorubicin Hydrochloride (NorthStar RxLLC)
Welcome to the PulseAid listing for the Doxorubicin Hydrochloride drug offered from NorthStar RxLLC. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | NorthStar RxLLC |
| NON-PROPRIETARY NAME: | Doxorubicin Hydrochloride |
| SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTABLE, LIPOSOMAL |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-29 |
| END MARKETING DATE: | 0000-00-00 |
Doxorubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Doxorubicin Hydrochloride from NorthStar RxLLC |
| LABELER NAME: | NorthStar RxLLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2017-08-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 16714-742_480ce0cc-d57e-e34e-3748-d51d94acd256 |
| PRODUCT NDC: | 16714-742 |
| APPLICATION NUMBER: | ANDA208657 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
